<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28811" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Seborrheic Dermatitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tucker</surname>
            <given-names>Dan</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Masood</surname>
            <given-names>Sadia</given-names>
          </name>
          <aff>Aga Khan University Hospital karachi</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dan Tucker declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sadia Masood declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28811.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Seborrheic dermatitis (SD) is a common papulosquamous skin disease occurring predominantly in infancy and middle age, exhibiting distinct variations across these age groups.&#x000a0;Characterized by&#x000a0;folliculocentric salmon-colored papules and plaques with a fine white scale and a yellowish crust (often described as a greasy scale-crust), SD manifests diversely across different body areas and may&#x000a0;present in&#x000a0;multiple locations. Because it often resembles other dermatoses, SD necessitates accurate differentiation. Notably, flexural surfaces typically display lesser scaling, with poorly defined margins.</p>
        <p>This activity delineates the nuanced manifestations of SD in infants, presenting as greasy scales on the scalp, reassuring clinicians about its typically mild, self-resolving nature within the first year of life. Conversely, the adult variant of SD showcases a relapsing and remitting disease pattern, significantly impacting quality of life.&#x000a0;Emphasizing the importance of tailored management approaches for varying disease stages,&#x000a0;the source discussion reviews&#x000a0;how distinct presentations of SD influence treatment decisions, thereby enhancing clinicians' skills in optimizing therapeutic outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess the burden of&#x000a0;SD from an epidemiological, clinical, and economic perspective and be aware of its potential to impair quality of life.</p></list-item><list-item><p>Identify the hypotheses concerned with understanding the diverse pathophysiological mechanisms underlying the development of SD.</p></list-item><list-item><p>Determine the various dermatoses that morphologically resemble&#x000a0;SD and differentiate the latter from the rest based on characteristic clinical features.</p></list-item><list-item><p>Develop an evidence-based formulary for treating&#x000a0;SD that includes conservative measures, over-the-counter products, and prescription treatments that are age-appropriate and likely to improve compliance, along with facilitating the variation of treatment at home.&#x000a0;</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28811&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28811">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28811.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Seborrheic dermatitis (SD) is a common inflammatory skin disease presenting with a papulosquamous morphology in areas rich in sebaceous glands, particularly the scalp, face, and body folds.<xref ref-type="bibr" rid="article-28811.r1">[1]</xref>&#x000a0;Two variants of SD reflect the condition's bimodal occurrence:&#x000a0;infantile SD (ISD) and adult SD (ASD).</p>
        <p>Infants are usually extensively affected by SD, which&#x000a0;often appears as firm, greasy scales on the crown and frontal regions of the scalp that can cause significant parental anxiety. ISD occurs&#x000a0;during the first&#x000a0;3 months of life; it is mild, self-limiting, and, in most cases, resolves&#x000a0;spontaneously by the first year of life.</p>
        <p>ASD, on the other hand, is characterized by a relapsing&#x000a0;and remitting pattern of disease and is&#x000a0;ranked third behind atopic&#x000a0;and contact dermatitis for its potential to impair&#x000a0;patients' quality of life.<xref ref-type="bibr" rid="article-28811.r2">[2]</xref></p>
      </sec>
      <sec id="article-28811.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>There are multiple factors associated with the development of SD, and their disparate nature has led to many proposals about its cause and pathogenesis.&#x000a0;The onset of SD appears linked to the interplay of normal microscopic skin flora (especially <italic toggle="yes">Malassezia</italic> spp.), the composition of lipids on the skin surface, and individual susceptibility.<xref ref-type="bibr" rid="article-28811.r3">[3]</xref><xref ref-type="bibr" rid="article-28811.r4">[4]</xref>&#x000a0;Neither the level of sebum produced nor the amount of yeast appears to be significant factors.<xref ref-type="bibr" rid="article-28811.r5">[5]</xref></p>
      </sec>
      <sec id="article-28811.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The worldwide prevalence of&#x000a0;SD is around 5%, but most of its noninflammatory variant, dandruff, is probably closer to 50%.<xref ref-type="bibr" rid="article-28811.r6">[6]</xref>&#x000a0;SD affects all ethnic groups in all regions globally.<xref ref-type="bibr" rid="article-28811.r7">[7]</xref>&#x000a0;The prevalence of SD is bimodal, with a peak in the first&#x000a0;3 months of life and from adrenarche to a second peak after the fourth decade. In Australian preschool children, SD prevalence was approximately 72% at&#x000a0;3 months, then fell rapidly with an overall incidence of 10%. Furthermore, the Rotterdam Study data analysis found that 14% of middle-aged and elderly adults had SD.<xref ref-type="bibr" rid="article-28811.r8">[8]</xref>&#x000a0;In patients with HIV-AIDS, however, 35% of those with early HIV infection have SD, and the prevalence reaches 85% in patients with AIDS.<xref ref-type="bibr" rid="article-28811.r9">[9]</xref></p>
        <p>
<bold>Risk factors </bold>
</p>
        <p>Risk factors&#x000a0;for the development of SD include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Age&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Male sex&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Increased sebaceous gland activity&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Immunodeficiency, including:<xref ref-type="bibr" rid="article-28811.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Lymphoma</p>
              </list-item>
              <list-item>
                <p>Renal transplantation</p>
              </list-item>
              <list-item>
                <p>HIV-AIDS</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Neurological&#x000a0;and psychiatric diseases, including<xref ref-type="bibr" rid="article-28811.r11">[11]</xref>:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Parkinson disease&#x000a0;<xref ref-type="bibr" rid="article-28811.r12">[12]</xref></p>
              </list-item>
              <list-item>
                <p>Stroke</p>
              </list-item>
              <list-item>
                <p>Alzheimer dementia</p>
              </list-item>
              <list-item>
                <p>Major depression</p>
              </list-item>
              <list-item>
                <p>Autonomic dysfunction</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Exposure to drug treatment, including:</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Dopamine antagonists</p>
              </list-item>
              <list-item>
                <p>Immunosuppressants</p>
              </list-item>
              <list-item>
                <p>Psoralen and psoralen plus ultraviolet A (PUVA)</p>
              </list-item>
              <list-item>
                <p>Lithium</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Low ambient humidity aandlow ambient temperature&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28811.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The proposed Mechanisms for the Pathogenesis of&#x000a0;SD include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Disruption of the skin&#x02019;s microbiota</p>
          </list-item>
          <list-item>
            <p>An impaired immune reaction to <italic toggle="yes">Malassezia</italic> spp. associated with a diminished T-cell response and activation of complement&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The increased presence of unsaturated fatty acids on the skin surface&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Disruption of cutaneous neurotransmitters&#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Abnormal shedding of keratinocytes</p>
          </list-item>
          <list-item>
            <p>Epidermal barrier disturbances associated with genetic factors&#x000a0;<xref ref-type="bibr" rid="article-28811.r13">[13]</xref></p>
          </list-item>
        </list>
        <p>The role of <italic toggle="yes">Malassezia</italic> spp. also includes the degradation of sebum&#x000a0;and consumption of saturated fatty acids, disrupting the lipid balance on the skin surface.<xref ref-type="bibr" rid="article-28811.r14">[14]</xref>&#x000a0;Further evidence for the involvement of <italic toggle="yes">Malassezia</italic> spp. includes their isolation from SD lesions and&#x000a0;the significant resolution of SD with antifungal treatment.</p>
      </sec>
      <sec id="article-28811.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The dermatopathology of&#x000a0;SD is nonspecific, but the surface and infundibular epidermis usually show a superficial perivascular infiltrate of lymphocytes, acanthosis, focal spongiosis, and focal parakeratosis.<xref ref-type="bibr" rid="article-28811.r15">[15]</xref><xref ref-type="bibr" rid="article-28811.r14">[14]</xref>&#x000a0;"Shoulder parakeratosis" refers to scale-crust accumulation around the infundibular ostia, which is appreciated in patients. <italic toggle="yes">Malassezia </italic>spp. may be present in the stratum corneum.</p>
        <p>Histological progression from acute to chronic SD characteristically demonstrates a transition from spongiosis to psoriasiform hyperplasia and the development of a lichenoid lymphocytic infiltrate. Severe SD is often associated with keratinocyte necrosis, focal interface destruction, and leukocytoclasia.</p>
      </sec>
      <sec id="article-28811.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The distribution of lesions is the most important clinical feature of SD, with lesions occurring in areas where the skin is rich in sebaceous glands, especially on the scalp and face.<xref ref-type="bibr" rid="article-28811.r16">[16]</xref>&#x000a0;ISD is generally asymptomatic, but atopic dermatitis frequently coexists. On the other hand, pruritus is common in ASD, especially with scalp lesions, and patients regularly report burning, but there is usually no history of atopic dermatitis.&#x000a0;SD characteristically demonstrates folliculocentric salmon-colored papules and plaques with a fine white scale and a yellowish crust often described as a greasy scale crust. It may present in one or more locations, with less scaling on flexural surfaces, and with lesions whose margins tend to be poorly defined.</p>
        <p>The mildest form of SD is a noninflammatory variant commonly called pityriasis capitis or sicca.<xref ref-type="bibr" rid="article-28811.r14">[14]</xref>&#x000a0;It affects the scalp&#x000a0;and "beard region" and is associated with the shedding of small light-colored flakes of skin, often seen on a background of dark clothing as "dandruff." The sudden onset of severe SD should be a red flag for the presence of HIV-AIDS, with early recognition and diagnosis of HIV-AIDS significantly improving long-term outcomes. Common clinical presentations include reddening of the face, scaling, and dandruff. On darker skin, there may be persistent dyschromia with variable hyper- and hypo-pigmentation.</p>
        <p>Other conditions associated with <italic toggle="yes">Malassezia spp.</italic> may be present, including pityriasis versicolor&#x000a0;and <italic toggle="yes">Pityrosporum</italic>&#x000a0;or <italic toggle="yes">Malassezia</italic> folliculitis in adults and neonatal cephalic pustulosis.<xref ref-type="bibr" rid="article-28811.r17">[17]</xref>&#x000a0;Lesions on the anterior chest tend to have a psoriasiform morphology but frequently have a petaloid appearance, with such annular lesions commonly observed on the face in darker skin phenotypes. A pityriasiform variation (with a collarette scale mimicking pityriasis rosea) is rare.</p>
        <p>
<bold>ASD</bold>
</p>
        <p>The face, scalp, and chest are&#x000a0;the&#x000a0;sites most commonly involved in ASD, with&#x000a0;around 88%, 70%, and 27% of cases developing lesions in these areas, respectively.<xref ref-type="bibr" rid="article-28811.r18">[18]</xref>&#x000a0;On the head&#x000a0;and neck,&#x000a0;SD is characteristically symmetrical and involves the central third of the face, including the malar region, the center of the forehead, the eyebrows (especially their medial aspects), the postauricular area, and the external ear canal. SD characteristically affects the nasolabial and alar folds, and blepharitis is a common finding with the involvement of the anterior (lash) line.</p>
        <p>Psoriasis requires differentiating from SD in adults.<xref ref-type="bibr" rid="article-28811.r19">[19]</xref>&#x000a0;It is characterized by indurated red papules&#x000a0;and plaques with a sharply defined margin and a loose, silvery lamella scale. The nails may show psoriatic changes, and the Auspitz sign is positive. The existence of sebopsoriasis as a separate clinical entity has come into dispute.<xref ref-type="bibr" rid="article-28811.r11">[11]</xref></p>
        <p>
<bold>ISD</bold>
</p>
        <p>ISD usually appears in the second week of life and tends to last 4 to 6 months. It can be present in the same facial distribution as that of ASD, the diaper region, the skin creases of the neck, and the axillae. The rash is usually not itchy or painful, and the infants look content, but parents may be distressed. It is generally mild&#x000a0;and self-limiting. A common presentation&#x000a0;known as&#x000a0;cradle cap refers to an adherent yellowish scale-crust that arises on the crown and front of the scalp, developing from a bran-like scale, serous ooze, and a greasy crust, to create a firm mass that may progress to involve the whole scalp.<xref ref-type="bibr" rid="article-28811.r20">[20]</xref></p>
        <p>Pityriasis&#x000a0;amiantacea may be present in ISD.<xref ref-type="bibr" rid="article-28811.r21">[21]</xref> It represents a set of clinical findings that may occur in older infants or young children but is not specific to seborrheic dermatitis.<xref ref-type="bibr" rid="article-28811.r22">[22]</xref> Typically, there are thick, silvery, or yellow scales enveloping scalp hairs and binding them in tufts, and can also be present in scalp psoriasis, atopic dermatitis, and tinea capitis. Atopic dermatitis is important in the differential diagnosis of ISD. It tends to be pruritic&#x000a0;and prone to weeping and typically occurs on the face&#x000a0;and limb flexures (elbow and knee) and spares the trunk. The child tends to be upset by the rash, and scratch marks are common.</p>
      </sec>
      <sec id="article-28811.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>It is not necessary to routinely investigate SD, but HIV serology should be expedited in cases of severe SD, especially where the onset is sudden.<xref ref-type="bibr" rid="article-28811.r23">[23]</xref>&#x000a0;Clinical features of Parkinson disease require recognition in elderly patients.&#x000a0;The patient&#x02019;s medications require a review as well.</p>
        <p>The following tests may be helpful in the diagnosis of SD and its associated pathologies:</p>
        <list list-type="bullet">
          <list-item>
            <p>Potassium hydroxide (KOH) examination of skin scrapings</p>
          </list-item>
          <list-item>
            <p>Swab for microscopy, culture, and sensitivities</p>
          </list-item>
          <list-item>
            <p>Histology&#x000a0;and direct immunofluorescence</p>
          </list-item>
          <list-item>
            <p>HIV serology; Venereal Disease Research Laboratory (VDRL)</p>
          </list-item>
          <list-item>
            <p>Serum zinc levels</p>
          </list-item>
          <list-item>
            <p>Antinuclear&#x000a0;antibodies (ANA); extractable nuclear antigens (ENA); erythrocyte sedimentation rate (ESR)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28811.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The approach to treating SD&#x000a0;varies according to the patient&#x02019;s age and the distribution&#x000a0;and severity of the condition. Discussing good general skincare practices, including using a soap substitute and appropriate moisturizing, is essential.<xref ref-type="bibr" rid="article-28811.r24">[24]</xref>&#x000a0;Treatments should address the underlying disease process and any secondary features, especially the hyperkeratotic scale, Staphylococcal infection, and associated symptoms, particularly pruritus.&#x000a0;</p>
        <p>A Danish expert group recommended that authorities adopt topical antifungals as first-line treatment and agreed that topical corticosteroids&#x000a0;and calcineurin inhibitors should only be used for significant symptoms and to manage moderate to severe flare-ups.<xref ref-type="bibr" rid="article-28811.r25">[25]</xref>&#x000a0;In ISD, removing the scale crust in the cradle cap and dealing with parental anxiety are important considerations.<xref ref-type="bibr" rid="article-28811.r26">[26]</xref>&#x000a0;Sorbolene cream or lotion and a soft-bristled toothbrush can soften and remove the cradle cap scales. On the other hand, it is crucial to relieve itch and discomfort in ASD.&#x000a0;</p>
        <p>A typical formulary should include antifungals, keratolytics, antipruritics, and antiinflammatories (topical corticosteroids&#x000a0;and calcineurin inhibitors).&#x000a0;Moreover, treatment rotation may be more effective and associated with fewer adverse reactions than persisting with monotherapy.&#x000a0;For scalp&#x000a0;and nonscalp SD treatment, evidence supports topical 1%&#x000a0;to 2% ketoconazole, 1% ciclopirox, 1% zinc pyrithione, and 1% hydrocortisone.<xref ref-type="bibr" rid="article-28811.r27">[27]</xref>&#x000a0;Intermittent use of a mild topical corticosteroid&#x000a0;and imidazole antifungal combination is convenient and can be very effective, but a potent corticosteroid may be necessary for the short-term treatment of scalp ASD.&#x000a0;</p>
        <p>Shampoos usually contain combinations of agents such as pine or coal tar (antipruritic/keratolytic), salicylic acid (keratolytic), sulfur (antimicrobial/keratolytic), and sulfacetamide (antiinflammatory/antibacterial). The patient can apply these to the scalp&#x000a0;and nonscalp regions and wash them off after 5&#x000a0;to 10 minutes. Given the lack of safety and efficacy data to inform such treatment, care should be taken when using topical salicylic acid, selenium, or zinc for treating ISD. Still, topical ketoconazole has been shown to be safe in infants, with minimal systemic absorption detected.</p>
        <p>Side effects associated with topical corticosteroids should be mitigated by intermittent use of site-appropriate potencies or steroid-sparing preparations such as topical 1% pimecrolimus. Another strategy is to employ the inherent antiinflammatory effect of the topical antifungals, estimated to be equivalent to 1% hydrocortisone.<xref ref-type="bibr" rid="article-28811.r28">[28]</xref>&#x000a0;</p>
        <p>Oral treatment should be a consideration for generalized or refractory disease, and the standard of care utilizes the antifungal&#x000a0;and antiinflammatory properties of ketoconazole (monitor liver function; Black Box warning), itraconazole (check for CYP450 drug interactions; can worsen heart failure), and fluconazole (adjust the dose according to renal function). Itraconazole has the greatest antiinflammatory effect,&#x000a0;whereas oral terbinafine may be more effective than oral fluconazole in severe SD. Low-dose isotretinoin is noninferior to the topical standard of care but is commonly associated with significant mucocutaneous side effects.<xref ref-type="bibr" rid="article-28811.r29">[29]</xref></p>
        <p>Itraconazole is safe and effective for controlling the flares of SD and preventing relapses.<xref ref-type="bibr" rid="article-28811.r28">[28]</xref>&#x000a0;It has also been shown to improve the quality of life in patients with moderate-to-severe SD.<xref ref-type="bibr" rid="article-28811.r30">[30]</xref>&#x000a0;However, given the absence of high-quality safety and efficacy data, a specialist team review is recommended before commencing oral treatment for ISD. In HIV-AIDS, antiretroviral treatment frequently improves SD, and SD may improve with L-dopa therapy in Parkinson disease.<xref ref-type="bibr" rid="article-28811.r31">[31]</xref>&#x000a0;Future therapies for SD could target improving skin barrier function or restoring the skin&#x02019;s surface lipid composition.</p>
        <p>
<bold>Typical Formulary</bold>
</p>
        <p>
<bold>Topical Creams, Ointments, and Lotions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>2% salicylic acid + 2% sulfur in sorbolene cream or emulsifying ointment&#x000a0;<xref ref-type="bibr" rid="article-28811.r32">[32]</xref></p>
          </list-item>
          <list-item>
            <p>2% ketoconazole cream</p>
          </list-item>
          <list-item>
            <p>1% clotrimazole + 1% hydrocortisone cream</p>
          </list-item>
          <list-item>
            <p>10% sulfacetamide + 5% sulfur lotion&#x000a0;<xref ref-type="bibr" rid="article-28811.r33">[33]</xref></p>
          </list-item>
          <list-item>
            <p>Betamethasone dipropionate 0.05% lotion</p>
          </list-item>
          <list-item>
            <p>0.03% and 0.1% tacrolimus&#x000a0;ointment</p>
          </list-item>
        </list>
        <p>
<bold>Shampoos</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>1% zinc pyrithione</p>
          </list-item>
          <list-item>
            <p>1%&#x000a0;to .5% selenium sulfide</p>
          </list-item>
          <list-item>
            <p>2% ketoconazole</p>
          </list-item>
          <list-item>
            <p>1% ciclopirox</p>
          </list-item>
          <list-item>
            <p>5% coal tar + 2% salicylic acid</p>
          </list-item>
          <list-item>
            <p>0.1%&#x000a0;and 0.03% tacrolimus</p>
          </list-item>
        </list>
        <p>
<bold>Oral Medication</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Itraconazole</p>
          </list-item>
          <list-item>
            <p>Fluconazole</p>
          </list-item>
          <list-item>
            <p>Terbinafine</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28811.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Important considerations in the differential diagnosis of ASD include:</p>
        <p>
<bold>Scalp</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Psoriasis:</bold> Mostly nonpruritic and tends to affect the occipital and frontal regions, whereas SD tends to affect the vertex and parietal regions</p>
          </list-item>
          <list-item>
            <p><bold>Eczema (contact):</bold>&#x000a0;Due to the use of different shampoos and hair dye</p>
          </list-item>
          <list-item>
            <p><bold>Darier disease:</bold>&#x000a0;Yellowish-brown clusters of rough dome-shaped papules in seborrheic distribution; acanthosis; peculiar odor&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Face</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Psoriasis:</bold>&#x000a0;Rarely occurs in isolation; pitted nails&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Lupus erythematosus (LE):</bold>&#x000a0;Discoid LE is associated with skin atrophy&#x000a0;and scarring alopecia</p>
          </list-item>
          <list-item>
            <p><bold>Rosacea:</bold> Look for erythema&#x000a0;and telangiectasia; may cause meibomianitis along the posterior lid line</p>
          </list-item>
          <list-item>
            <p><bold>Acne vulgaris:</bold>&#x000a0;Look for comedones (hallmark feature)</p>
          </list-item>
          <list-item>
            <p>
<bold>Staphylococcal blepharitis (anterior lash line)</bold>
</p>
          </list-item>
          <list-item>
            <p><bold>Eczema (contact):</bold>&#x000a0;Eyelids commonly involved (versus irritant eczema&#x000a0;[dry, scaly skin]&#x000a0;or&#x000a0;allergic eczema&#x000a0;[swollen, vesicular skin rash])</p>
          </list-item>
          <list-item>
            <p><bold>Darier disease:&#x000a0;</bold>Nail changes&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Trunk</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Psoriasis:</bold>&#x000a0;Sharply-defined red plaques with a loose, silvery lamella scale</p>
          </list-item>
          <list-item>
            <p><bold>Pityriasis rosea: </bold>Herald spot; collarette scale; Christmas tree distribution</p>
          </list-item>
          <list-item>
            <p><bold>Pityriasis versicolor:</bold>&#x000a0;Not symmetrical; hypo- or hyperpigmentation</p>
          </list-item>
          <list-item>
            <p><bold>Subacute LE:</bold>&#x000a0;Photosensitive distribution</p>
          </list-item>
          <list-item>
            <p><bold>Eczema (nummular): </bold>Intense pruritus</p>
          </list-item>
          <list-item>
            <p><bold>Tinea corporis:</bold>&#x000a0;Raised leading edges&#x000a0;and central clearing; uncommon in infants</p>
          </list-item>
          <list-item>
            <p><bold>Erythema annulare centrifugum: </bold>Recurrent polycyclic lesions that slowly expand and disappear</p>
          </list-item>
          <list-item>
            <p><bold>Darier disease:</bold>&#x000a0;Greasy wart-like papules and plaques</p>
          </list-item>
          <list-item>
            <p><bold>Grover disease (transient acantholytic dermatosis):</bold>&#x000a0;Acanthosis</p>
          </list-item>
          <list-item>
            <p><bold>Drug reaction: </bold>Drug history (neuroleptic; immunosuppressant; PUVA; lithium)</p>
          </list-item>
          <list-item>
            <p><bold>Parapsoriasis:</bold>&#x000a0;Elderly; very slow growing; resistant to treatment</p>
          </list-item>
          <list-item>
            <p><bold>Pemphigus foliaceus: </bold>Fragile, painful blisters; Nikolsky sign is positive</p>
          </list-item>
          <list-item>
            <p><bold>Secondary syphilis: </bold>Lesions on the palms&#x000a0;and soles; a history of chancre</p>
          </list-item>
        </list>
        <p>
<bold>Intertriginous Areas</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Psoriasis (inverse):</bold>&#x000a0;Sharply-defined border</p>
          </list-item>
          <list-item>
            <p><bold>Dermatitis (Contact)</bold>&#x000a0;Itchy; vesicular</p>
          </list-item>
          <list-item>
            <p><bold>Tinea cruris:&#x000a0;</bold>Advancing border; very uncommon in infants</p>
          </list-item>
          <list-item>
            <p><bold>Erythrasma:</bold>&#x000a0;Coral-red fluorescence under Wood Lamp</p>
          </list-item>
          <list-item>
            <p><bold>Candidiasis:&#x000a0;</bold>Satellite lesions; obesity; a history of immunodeficiency</p>
          </list-item>
          <list-item>
            <p><bold>Hailey-Hailey disease (familial benign pemphigus):&#x000a0;</bold>Acanthosis</p>
          </list-item>
        </list>
        <p>Important considerations in the differential diagnosis&#x000a0;of ISD include:</p>
        <p>
<bold>Cradle Cap</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Tinea capitis:</bold>&#x000a0;Look for broken hairs or &#x0201c;black dots&#x0201d;; very uncommon in adults</p>
          </list-item>
          <list-item>
            <p><bold>Impetigo:</bold>&#x000a0;Yellow, honey-colored crusting</p>
          </list-item>
        </list>
        <p>
<bold>Diaper Region</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Irritant contact dermatitis:</bold> Tends to spare the skin folds</p>
          </list-item>
          <list-item>
            <p><bold>Candidiasis: </bold>Either secondary or from colonization with fecal yeast; look for satellite lesions</p>
          </list-item>
          <list-item>
            <p><bold>Infantile psoriasis: </bold>Sharply-defined red plaques with silver scale</p>
          </list-item>
          <list-item>
            <p><bold>Histiocytosis X (Langerhans cell histiocytosis):</bold>&#x000a0;Tends to be confined to the skin folds with a purpuric rash on the body</p>
          </list-item>
          <list-item>
            <p><bold>Acrodermatitis enteropathica:</bold>&#x000a0;Look for periorificial involvement and check zinc levels</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28811.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>ISD usually affects the scalp and is mild&#x000a0;and self-limiting, whereas ASD presents a chronic pattern of skin disease characterized by relapses&#x000a0;and remissions.</p>
        <p>ASD is very controllable but not curable.&#x000a0;Although&#x000a0;the disease does take a toll on the well-being of patients, timely management can help increase the quality of life.<xref ref-type="bibr" rid="article-28811.r34">[34]</xref></p>
      </sec>
      <sec id="article-28811.s12" sec-type="Complications">
        <title>Complications</title>
        <p>SD usually takes a benign course, and serious complications are very rare. The intertriginous areas&#x000a0;and eyelids are prone to secondary bacterial infections, especially during acute flares, and the diaper region is particularly prone to overgrowth with <italic toggle="yes">Candida</italic> spp.</p>
        <p>Erythroderma has been reported in immunosuppressed neonates with generalized ISD, but it is more frequently a feature in adults with HIV-AIDS. However, research has not firmly established that SD&#x000a0;causes erythroderma per se, given its predilection for sebaceous-rich skin.<xref ref-type="bibr" rid="article-28811.r11">[11]</xref><xref ref-type="bibr" rid="article-28811.r17">[17]</xref>&#x000a0;The most common problems associated with both ISD and ASD relate to misdiagnosis of the condition.<xref ref-type="bibr" rid="article-28811.r35">[35]</xref></p>
      </sec>
      <sec id="article-28811.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Parental education is&#x000a0;helpful in allaying anxiety associated with ISD, and well-informed adults can learn to be confident in managing their condition,</p>
        <p>For ASD,&#x000a0;patient education&#x000a0;requires emphasizing that there is no cure, but the condition can be well-controlled and managed primarily&#x000a0;at home.<xref ref-type="bibr" rid="article-28811.r25">[25]</xref></p>
        <p>Many treatments for SD are available without a prescription, over the counter at the pharmacy, or increasingly on supermarket shelves. Directing the patient to the selection of such products may save consultation time and associated costs.</p>
      </sec>
      <sec id="article-28811.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>SD is a difficult condition to manage in adults, and it is best done by an interprofessional team. A few important considerations:</p>
        <list list-type="bullet">
          <list-item>
            <p>Consider the impact of SD on psychosocial functioning&#x000a0;and quality of life, and remember that SD may accompany neurological or psychiatric disease.<xref ref-type="bibr" rid="article-28811.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>The dermatologist&#x000a0;and pharmacist can help to promote the appropriate use of topical corticosteroids and employ steroid-sparing alternatives.</p>
          </list-item>
          <list-item>
            <p>New evidence suggests diet may play a role in SD, with a high fruit intake associated with a 25% lower risk of SD, whereas a "Western" diet was associated with a 47% increased risk of SD.<xref ref-type="bibr" rid="article-28811.r37">[37]</xref>&#x000a0;Proper diet counseling sessions with a dietician can help the patient.&#x000a0;</p>
          </list-item>
        </list>
        <p>Even though primary clinicians manage the condition, it is best to refer the complex patient to the dermatologist for guidance. Dermatology specialty&#x02013;trained nurses can also help by counseling the patient, providing direction on medical management, and monitoring and charting treatment progress. A pharmacist should also be on the case, with assistance in selecting the most appropriate agents, verifying dosing, offering patient education, performing medication reconciliation, and informing the prescriber of any issues encountered. Close communication between interprofessional team members is vital for better patient management.</p>
      </sec>
      <sec id="article-28811.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28811&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28811">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/seborrheic-dermatitis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28811">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28811/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28811">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28811.s16">
        <fig id="article-28811.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Infantile Seborrhoeic Dermatitis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="infantile__seborrhoeic__dermatitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28811.s17">
        <fig id="article-28811.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Seborrhoeic Dermatitis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="seborrhoeic__dermatitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28811.s18">
        <fig id="article-28811.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Seborrheic Dermatitis Contributed by S bhimji, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="seborrhea" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28811.s19">
        <fig id="article-28811.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Seborrheic dermatitis Contributed by Dr. Hasnain Ali Syed</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="SD__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28811.s20">
        <fig id="article-28811.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Seborrheic Dermatitis seen on the scalp extending to forehead. Contributed by Dr. Hasnain Ali Syed</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="SD" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28811.s21">
        <title>References</title>
        <ref id="article-28811.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heath</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Usatine</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Seborrheic dermatitis.</article-title>
            <source>J Fam Pract</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>70</volume>
            <issue>9</issue>
            <fpage>E3</fpage>
            <page-range>E3-E4</page-range>
            <pub-id pub-id-type="pmid">34818158</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sampogna</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Piaserico</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Altomare</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bortune</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Calzavara-Pinton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vedove</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Girolomoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Peserico</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sala</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abeni</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>411</fpage>
            <page-range>411-4</page-range>
            <pub-id pub-id-type="pmid">24287710</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wikramanayake</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Borda</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Miteva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Paus</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Seborrheic dermatitis-Looking beyond Malassezia.</article-title>
            <source>Exp Dermatol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>991</fpage>
            <page-range>991-1001</page-range>
            <pub-id pub-id-type="pmid">31310695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Panchamukhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Malassezia and Staphylococcus dominate scalp microbiome for seborrheic dermatitis.</article-title>
            <source>Bioprocess Biosyst Eng</source>
            <year>2021</year>
            <month>May</month>
            <volume>44</volume>
            <issue>5</issue>
            <fpage>965</fpage>
            <page-range>965-975</page-range>
            <pub-id pub-id-type="pmid">32219537</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zani</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Arruda</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>de Arruda</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Paulino</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Ketoconazole does not decrease fungal amount in patients with seborrhoeic dermatitis.</article-title>
            <source>Br J Dermatol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>175</volume>
            <issue>2</issue>
            <fpage>417</fpage>
            <page-range>417-21</page-range>
            <pub-id pub-id-type="pmid">26920094</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Skin microbiome alterations in seborrheic dermatitis and dandruff: A systematic review.</article-title>
            <source>Exp Dermatol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>30</volume>
            <issue>10</issue>
            <fpage>1546</fpage>
            <page-range>1546-1553</page-range>
            <pub-id pub-id-type="pmid">34415635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palamaras</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Kyriakis</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Stavrianeas</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Seborrheic dermatitis: lifetime detection rates.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>524</fpage>
            <page-range>524-6</page-range>
            <pub-id pub-id-type="pmid">21521374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanders</surname>
                <given-names>MGH</given-names>
              </name>
              <name>
                <surname>Pardo</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Ginger</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Nijsten</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and determinants of seborrhoeic dermatitis in a middle-aged and elderly population: the Rotterdam Study.</article-title>
            <source>Br J Dermatol</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>178</volume>
            <issue>1</issue>
            <fpage>148</fpage>
            <page-range>148-153</page-range>
            <pub-id pub-id-type="pmid">28856679</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scognamiglio</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chiaradia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>De Carli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Giuliani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mastroianni</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Aviani Barbacci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Buonomini</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Grisetti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sampaolesi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Corpolongo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Orchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Puro</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ippolito</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Girardi</surname>
                <given-names>E</given-names>
              </name>
              <collab>SENDIH Study Group</collab>
            </person-group>
            <article-title>The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis.</article-title>
            <source>BMC Infect Dis</source>
            <year>2013</year>
            <month>Oct</month>
            <day>10</day>
            <volume>13</volume>
            <fpage>473</fpage>
            <pub-id pub-id-type="pmid">24112129</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lally</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casabonne</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Imko-Walczuk</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wojnarowska</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of benign cutaneous disease among Oxford renal transplant recipients.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2011</year>
            <month>Apr</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>462</fpage>
            <page-range>462-70</page-range>
            <pub-id pub-id-type="pmid">20738465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dessinioti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Katsambas</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.</article-title>
            <source>Clin Dermatol</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>343</fpage>
            <page-range>343-351</page-range>
            <pub-id pub-id-type="pmid">23806151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Niemann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Billnitzer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jankovic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Parkinson's disease and skin.</article-title>
            <source>Parkinsonism Relat Disord</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>82</volume>
            <fpage>61</fpage>
            <page-range>61-76</page-range>
            <pub-id pub-id-type="pmid">33248395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adalsteinsson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kaushik</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Muzumdar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Guttman-Yassky</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ungar</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An update on the microbiology, immunology and genetics of seborrheic dermatitis.</article-title>
            <source>Exp Dermatol</source>
            <year>2020</year>
            <month>May</month>
            <volume>29</volume>
            <issue>5</issue>
            <fpage>481</fpage>
            <page-range>481-489</page-range>
            <pub-id pub-id-type="pmid">32125725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartz</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Messenger</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Tosti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hordinsky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zachariae</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Rust</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2013</year>
            <month>Mar</month>
            <day>27</day>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-7</page-range>
            <pub-id pub-id-type="pmid">22875203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sampaio</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Mameri</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Ramos-e-Silva</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Seborrheic dermatitis.</article-title>
            <source>An Bras Dermatol</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>86</volume>
            <issue>6</issue>
            <fpage>1061</fpage>
            <page-range>1061-71; quiz 1072-4</page-range>
            <pub-id pub-id-type="pmid">22281892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dall'Oglio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nasca</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Gerbino</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>An Overview of the Diagnosis and Management of Seborrheic Dermatitis.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2022</year>
            <volume>15</volume>
            <fpage>1537</fpage>
            <page-range>1537-1548</page-range>
            <pub-id pub-id-type="pmid">35967915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaitanis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Magiatis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hantschke</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bassukas</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Velegraki</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The Malassezia genus in skin and systemic diseases.</article-title>
            <source>Clin Microbiol Rev</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>106</fpage>
            <page-range>106-41</page-range>
            <pub-id pub-id-type="pmid">22232373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peyr&#x000ed;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lleonart</surname>
                <given-names>M</given-names>
              </name>
              <collab>Grupo espa&#x000f1;ol del Estudio SEBDERM</collab>
            </person-group>
            <article-title>[Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis].</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2007</year>
            <month>Sep</month>
            <volume>98</volume>
            <issue>7</issue>
            <fpage>476</fpage>
            <page-range>476-82</page-range>
            <pub-id pub-id-type="pmid">17669302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Szeto</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Sivesind</surname>
                <given-names>TE</given-names>
              </name>
              <name>
                <surname>Memon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Muneem</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Victoire</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Magin</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>van Driel</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Nashawaty</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dellavalle</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>From the Cochrane Library: Interventions for infantile seborrheic dermatitis (including cradle cap).</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>86</volume>
            <issue>2</issue>
            <fpage>e87</fpage>
            <page-range>e87-e88</page-range>
            <pub-id pub-id-type="pmid">34571061</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r20">
          <label>20</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Nobles</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Harberger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Krishnamurthy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Cradle Cap</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>7</day>
            <pub-id pub-id-type="pmid">30285358</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amorim</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis amiantacea: a study of seven cases.</article-title>
            <source>An Bras Dermatol</source>
            <year>2016</year>
            <season>Sep-Oct</season>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>694</fpage>
            <page-range>694-696</page-range>
            <pub-id pub-id-type="pmid">27828657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ayanlowo</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Olowoyo</surname>
                <given-names>OO</given-names>
              </name>
              <name>
                <surname>Akinkugbe</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Adelekan</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Ahamneze</surname>
                <given-names>NC</given-names>
              </name>
            </person-group>
            <article-title>Pityriasis amiantacea: a case report.</article-title>
            <source>Niger Postgrad Med J</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-8</page-range>
            <pub-id pub-id-type="pmid">25167599</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forrestel</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kovarik</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Mosam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Micheletti</surname>
                <given-names>RG</given-names>
              </name>
            </person-group>
            <article-title>Diffuse HIV-associated seborrheic dermatitis - a case series.</article-title>
            <source>Int J STD AIDS</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>14</issue>
            <fpage>1342</fpage>
            <page-range>1342-1345</page-range>
            <pub-id pub-id-type="pmid">27013615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Augustin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kirsten</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilsmann-Theis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Itschert</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Staubach-Renz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maul</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Zander</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, predictors and comorbidity of dry skin in the general population.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-150</page-range>
            <pub-id pub-id-type="pmid">29953684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hald</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arendrup</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Svejgaard</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Lindskov</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Foged</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Saunte</surname>
                <given-names>DM</given-names>
              </name>
              <collab>Danish Society of Dermatology</collab>
            </person-group>
            <article-title>Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>95</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-9</page-range>
            <pub-id pub-id-type="pmid">24556907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Victoire</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Magin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Coughlan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>van Driel</surname>
                <given-names>ML</given-names>
              </name>
            </person-group>
            <article-title>Interventions for infantile seborrhoeic dermatitis (including cradle cap).</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <day>04</day>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>CD011380</fpage>
            <pub-id pub-id-type="pmid">30828791</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheong</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Torsekar</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Ungpakorn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Widaty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Azizan</surname>
                <given-names>NZ</given-names>
              </name>
              <name>
                <surname>Gabriel</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Tran</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Chong</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Dall'Oglio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Seborrhoeic Dermatitis in Asia: A Consensus Guide.</article-title>
            <source>Skin Appendage Disord</source>
            <year>2016</year>
            <month>May</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>187</fpage>
            <page-range>187-96</page-range>
            <pub-id pub-id-type="pmid">27386464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Panda</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach.</article-title>
            <source>Indian J Dermatol</source>
            <year>2017</year>
            <season>May-Jun</season>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>237</fpage>
            <page-range>237-250</page-range>
            <pub-id pub-id-type="pmid">28584365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kamamoto</surname>
                <given-names>CSL</given-names>
              </name>
              <name>
                <surname>Nishikaku</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Gompertz</surname>
                <given-names>OF</given-names>
              </name>
              <name>
                <surname>Melo</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Hassun</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Bagatin</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Cutaneous fungal microbiome: <italic>Malassezia</italic> yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial.</article-title>
            <source>Dermatoendocrinol</source>
            <year>2017</year>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>e1361573</fpage>
            <pub-id pub-id-type="pmid">29484095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbas</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ghodsi</surname>
                <given-names>SZ</given-names>
              </name>
              <name>
                <surname>Abedeni</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Effect of itraconazole on the quality of life in patients with moderate to severe seborrheic dermatitis: a randomized, placebo-controlled trial.</article-title>
            <source>Dermatol Pract Concept</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>11</fpage>
            <page-range>11-6</page-range>
            <pub-id pub-id-type="pmid">27648378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skorvanek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bhatia</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <article-title>The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues.</article-title>
            <source>Mov Disord Clin Pract</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-31</page-range>
            <pub-id pub-id-type="pmid">30363435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Piquero-Casals</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>La Rotta-Higuera</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Francisco Mir-Bonaf&#x000e9;</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rozas-Mu&#x000f1;oz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Non-Steroidal Topical Therapy for Facial Seborrheic Dermatitis.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2020</year>
            <month>Jun</month>
            <day>01</day>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>658</fpage>
            <page-range>658-660</page-range>
            <pub-id pub-id-type="pmid">32574015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Versteeg</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>Topical Treatment of Facial Seborrheic Dermatitis: A Systematic Review.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-213</page-range>
            <pub-id pub-id-type="pmid">27804089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Araya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kulthanan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jiamton</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical Characteristics and Quality of Life of Seborrheic Dermatitis Patients in a Tropical Country.</article-title>
            <source>Indian J Dermatol</source>
            <year>2015</year>
            <season>Sep-Oct</season>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>519</fpage>
            <pub-id pub-id-type="pmid">26538714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwartz</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Clinton</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Darier's disease misdiagnosed as severe seborrheic dermatitis.</article-title>
            <source>Mil Med</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>176</volume>
            <issue>12</issue>
            <fpage>1457</fpage>
            <page-range>1457-9</page-range>
            <pub-id pub-id-type="pmid">22338367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e4;rna</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Aluoja</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kingo</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Quality of life and emotional state in chronic skin disease.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>95</volume>
            <issue>3</issue>
            <fpage>312</fpage>
            <page-range>312-6</page-range>
            <pub-id pub-id-type="pmid">24978135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28811.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanders</surname>
                <given-names>MGH</given-names>
              </name>
              <name>
                <surname>Pardo</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Ginger</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Kiefte-de Jong</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Nijsten</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Association between Diet and Seborrheic Dermatitis: A Cross-Sectional Study.</article-title>
            <source>J Invest Dermatol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>139</volume>
            <issue>1</issue>
            <fpage>108</fpage>
            <page-range>108-114</page-range>
            <pub-id pub-id-type="pmid">30130619</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
